Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 4/20 | 0.96 |
| ▸ | RCOR1 | Q9UKL0 | 3/20 | 0.85 |
| ▸ | LDHB | P07195 | 4/20 | 0.42 |
| ▸ | TERF2IP | Q9NYB0 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NPY1R | P25929 | 1/20 | 0.36 |
| ▸ | NPY2R | P49146 | 1/20 | 0.36 |
| ▸ | NPY4R | P50391 | 1/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | JAK1 | P23458 | 1/20 | 0.35 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.35 |
| ▸ | STAT1 | P42224 | 1/20 | 0.35 |
| ▸ | F11 | P03951 | 2/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | TERF2 | Q15554 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24437319 | 1.00 | KDM1A (0.96) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL16549279 | 1.00 | KDM1A (0.96) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL29360957 | 1.00 | KDM1A (0.96) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL29380446 | 1.00 | KDM1A (0.96) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL691747 | 1.00 | KDM1A (0.96) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL31066574 | 0.98 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL49226 | 0.98 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL18902532 | 0.98 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL21476977 | 0.98 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL21474097 | 0.97 | KDM1A (0.99) | KDM1ARCOR1LDHBTERF2IPESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117241773-A | Polymer medicine bottle with standard external dimensions and reduced internal volume | SIO2医疗产品有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-102228161-A | Compound feed for reducing nitrogen and phosphorus excretions of growing pigs | ZHENGZHOU COLLEGE ANIMAL HUSBANDRY ENG | 2011-11-02 | — | — | CN | claimed |
| CN-115666716-B | Lighting device for inducing biological effects | Nuo bio Co.,Ltd. (US) | 2026-05-26 | — | — | CN | disclosed |
| US-20260124224-A1 | USE OF COMBINED COMPOSITION IN PREPARING DRUG FOR RESISTING FUNGAL AND BACTERIAL INFECTIONS | NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY (CN) | 2026-05-07 | — | — | US | disclosed |
| WO-2026096690-A1 | COMPOSITIONS AND METHODS TO TREAT NEURODEGENERATION AND COGNITIVE DECLINE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-07 | — | — | WO | disclosed |
| WO-2026095932-A1 | COMPOSITIONS AND METHODS TO TREAT NEURODEGENERATION AND COGNITIVE DECLINE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-07 | — | — | WO | disclosed |
| EP-4731266-A1 | NANOPARTICLE COMPOSITIONS ASSOCIATED WITH PEPTIDES | The Regents of the University of Michigan (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260097045-A1 | ANTIMICROBIAL COMBINATIONS | HELPERBY THERAPEUTICS LIMITED (GB) | 2026-04-09 | — | — | US | disclosed |
| US-12594319-B2 | Pharmaceutical development | HELPERBY THERAPEUTICS LIMITED (GB) | 2026-04-07 | — | — | US | disclosed |
| US-12563857-B2 | Photovoltaic device including a p-n junction and method of manufacturing | FIRST SOLAR, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20260042800-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | BASILEA PHARMACEUTICA INT AG ALLSCHWIL (CH) | 2026-02-12 | — | — | US | disclosed |
| US-20160002296-A1 | POLYMYXINS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE | XELLIA PHARMACEUTICALS APS (DK) | 2016-01-07 | — | — | US | disclosed |
| EP-2943503-A1 | POLYMYXINS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE | Xellia Pharmaceuticals ApS (DK) | 2015-11-18 | — | — | EP | disclosed |
| CN-104918951-A | POLYMYXINS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE | XELLIA PHARMACEUTICALS APS | 2015-09-16 | — | — | CN | disclosed |
| WO-2014108469-A1 | POLYMYXINS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE | XELLIA PHARMACEUTICALS APS (DK) | 2014-07-17 | — | — | WO | disclosed |
| CN-103229746-A | Safe pig breeding method | SHAANXI SHIYANG GROUP FEED DEV CO LTD | 2013-08-07 | — | — | CN | disclosed |
| CN-102228161-A | Compound feed for reducing nitrogen and phosphorus excretions of growing pigs | ZHENGZHOU COLLEGE ANIMAL HUSBANDRY ENG | 2011-11-02 | — | — | CN | disclosed |
| US-7960164-B2 | Selective growth medium for Listeria spp | PARADIGM DIAGNOSTICS, INC. (US) | 2011-06-14 | — | — | US | disclosed |
| US-20080020445-A1 | Selective Growth Medium for Listeria Spp | PARADIGM DIAGNOSTICS, INC. | 2008-01-24 | — | — | US | disclosed |
| WO-2005079276-A2 | SELECTIVE GROWTH MEDIUM FOR LISTERIA SPP | PARADIGM DIAGNOSTICS, INC. (US) | 2005-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124224-A1 | USE OF COMBINED COMPOSITION IN PREPARING DRUG FOR RESISTING FUNGAL AND BACTERIAL INFECTIONS | ERG28, MYD88, SLC11A2 | KDM1A 3513/4885RCOR1 3373/4885LDHB 3796/4885 |
| US-12563857-B2 | Photovoltaic device including a p-n junction and method of manufacturing | DSP, SLC6A12, SLC6A6 | KDM1A 3884/4885RCOR1 4060/4885LDHB 4295/4885 |
| US-20160002296-A1 | POLYMYXINS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE | C5, SGMS1, SGMS2 | KDM1A 2574/4885RCOR1 2534/4885LDHB 3744/4885 |
| US-20260042800-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | CUTA, NGLY1, P4HB | KDM1A 3524/4885RCOR1 3762/4885LDHB 991/4885 |
| US-12594319-B2 | Pharmaceutical development | TMSB10, TMEM165, PCTP | KDM1A 3641/4885RCOR1 4874/4885LDHB 1914/4885 |
| US-20260097045-A1 | ANTIMICROBIAL COMBINATIONS | ZYX, TREH, PRF1 | KDM1A 3365/4885RCOR1 4649/4885LDHB 692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.